Trevi Therapeutics Inc.

Trevi Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization Haduvio to treat serious neurologically mediated conditions. It includes treatment of chronic pruritus associated with prurigo nodularis and chronic cough in patients with idiopathic pulmonary fibrosis, and levodopa-induced dyskinesia in patients with Parkinson’s disease. The company was founded by Thomas R. Sciascia and Jennifer L. Good in March 2011 and is headquartered in New Haven, CT.

Source link

You May Also Like

Julius Randle scores 36, Isaiah Hartenstein makes huge defensive stop to lead Knicks to win over Cavaliers, snapping four game losing streak

Isaiah Hartenstein heard the word from his coach so many times it…

Iran says drone attack targets defense facility in Isfahan

DUBAI, United Arab Emirates — Bomb-carrying drones targeted an Iranian defense factory…

Katie Porter berated Irvine mayor in texts: ‘lecture me’ on ‘professionalism’ and ‘see what happens’

FIRST ON FOX: California Democrat Rep. Katie Porter berated Irvine Mayor Farrah…

Darrell Brooks sentenced to life in prison for deadly Christmas parade attack

Darrell Brooks was sentenced Wednesday to life in prison without the possibility…